---
document_datetime: 2023-09-21 19:16:02
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/velosulin-epar-all-authorised-presentations_en.pdf
document_name: velosulin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8848653
conversion_datetime: 2025-12-26 21:15:16.233685
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical form                | Route of administration          | Packaging    | Content (concentration)   | Package size          |
|-----------------|-----------------|------------|------------------------------------|----------------------------------|--------------|---------------------------|-----------------------|
| EU/1/02/232/001 | Velosulin       | 100 IU/ml  | Solution for injection or infusion | Subcutaneous and intravenous use | Vial (glass) | 10ml (3.5 mg/ml)          | 1 vial                |
| EU/1/02/232/002 | Velosulin       | 100 IU/ml  | Solution for injection or infusion | Subcutaneous and intravenous use | Vial (glass) | 10 ml (3.5 mg/ml)         | 5 vials               |
| EU/1/02/232/003 | Velosulin       | 100 IU/ml  | Solution for injection or infusion | Subcutaneous and intravenous     | vial (glass) | 10 ml (3.5 mg/ml)         | 5 x (1 x 10 ml) vials |

## Medicinal product no longer authorised Strength Pharmaceutical form Route of administration 100 IU/ml Solution for injection or infusion Subcutaneous and intravenous use 100 IU/ml Solution for injection or infusion Subcutaneous and intravenous use 100 IU/ml Solution for injection or infusion Subcutaneous and intravenous use